144 results
Page 4 of 8
8-K
EX-10.1
llct9o5uol8allbpi1fe
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
8-K/A
EX-10.2
qela0 30gtekov
29 Sep 20
Departure of Directors or Certain Officers
4:39pm
8-K
EX-10.2
swodah
29 Sep 20
Departure of Directors or Certain Officers
7:06am
DEFA14A
02hqvdstaee dyedod
19 Aug 20
Additional proxy soliciting materials
6:13am
8-K
EX-99.2
o4pjmdj03i1667u3swho
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
EX-99.1
4a75t a55wbjwpxygat
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K/A
EX-99.2
3edr6j
26 Jun 20
Other Events
5:08pm
8-K
EX-99.1
rsa2u6uud1rz 3c
3 Jun 20
Regulation FD Disclosure
12:00am
8-K
EX-10.4
td5o qula
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.1
0w5v5ooy2f
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.2
7zqbb58qkycpbl
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
a43b889v qfha
29 Apr 20
Proxy related to merger
3:20pm